You have 9 free searches left this month | for more free features.

City

Beijing (1)

Stockholm (1)

Condition

Breast Cancer (1)

Immune Thrombocytopenia (1)

Liver Transplantation (1)

Renal Transplantation (1)

Overall Status

Recruiting (2)

Completed (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (3)

phase 3 (1)

Sponsor

ITB-Med LLC (2)

German Breast Group (1)

Peking University People's Hospital (1)

Collaborator

Amgen (1)

Roche Pharma AG (1)

Sanofi (1)

University Hospital Frankfurt (1)

Study Documents

Intervention Type

drug (4)

biological (2)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (4)

tac

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Liver Transplantation Trial in Stockholm (TCD601, Cyclophosphamide, TAC)

Recruiting

Liver Transplantation

TCD601
+4 more

Stockholm, Huddinge, Sweden

Karolinska University Hospital

Aug 25, 2023

Renal Transplantation Trial (TCD601, belatacept, ATG)

Not yet recruiting

Renal Transplantation

TCD601
+5 more

(no location specified)

Dec 20, 2022

Immune Thrombocytopenia Trial in Beijing (TAC, Danazol)

Recruiting

Immune Thrombocytopenia

TAC
Danazol

Beijing, Beijing, China

Peking University Insititute of Hematology, Peking University Pe

Jul 20, 2022

Breast Cancer Trial (TAC, NX)

Completed

Breast Cancer

TAC
NX

(no location specified)

Feb 2, 2021